Brief: Rua Bioscience Says Shareholders Approve Zalm Therapeutics Share Issue
19/01/2022 05:55
Jan 19 (Reuters) - Rua Bioscience Ltd RUA.NZ :
* SHAREHOLDERS APPROVE ZALM THERAPEUTICS SHARE ISSUE
* PURCHASE WILL BE UNDERTAKEN THROUGH ISSUE 28.7 MILLION
SHARES
OVER 3 YEARS TO ZALM THERAPEUTICS SHAREHOLDERS
* SHAREHOLDERS VOTED IN FAVOUR OF RUA ACQUIRING ZALM
THERAPEUTICS
* RUA EXPECTS TO FURTHER EXPAND PRODUCT OFFERING FOR
DOMESTIC &
GLOBAL MARKETS IN H2 OF 2022
Further company coverage: RUA.NZ
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Reports Research Partnership To Develop Smoking Cessation Products
Brief: Rua Bioscience Secures Exclusive NZ Distribution Rights For Medical Device
NZ's Rua Bioscience rises on securing exclusive dsitribution for medical device
Brief: Rua Bioscience Secures New Long-Term Supply Arrangement In Germany
NZ's Rua Bioscience falls to over three-month low on discounted capital raising